BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33636290)

  • 1. Genomic and immunological features of microsatellite instability in colon cancer.
    Luo Y; Yang Z; Chen Y; Lu X; Quan Y
    Gene; 2021 May; 781():145534. PubMed ID: 33636290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
    Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant
    Keshinro A; Vanderbilt C; Kim JK; Firat C; Chen CT; Yaeger R; Ganesh K; Segal NH; Gonen M; Shia J; Stadler Z; Weiser MR
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
    J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
    Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer with microsatellite instability displays increased thymidylate synthase expression.
    Pereira MA; Dias AR; Ramos MFKP; Cardili L; Moraes RDR; Zilberstein B; Nahas SC; Mello ES; Ribeiro U
    J Surg Oncol; 2022 Jul; 126(1):116-124. PubMed ID: 35689583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
    Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
    Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer.
    Akbari V; Kallhor M; Mollashahi B; Movafagh A
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2445-2454. PubMed ID: 31450919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
    Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between microsatellite instability and clinico-pathological characteristics in sporadic colon cancer].
    Guerrero D; Balen E; Martínez-Peñuela JM; García-Foncillas J; Larrinaga B; Caballero MC; Herrera J; Lera JM
    Med Clin (Barc); 2005 Apr; 124(12):441-6. PubMed ID: 15826579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional profiles underpin microsatellite status and associated features in colon cancer.
    Hogan J; DeJulius K; Liu X; Coffey JC; Kalady MF
    Gene; 2015 Oct; 570(1):36-43. PubMed ID: 25704535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer.
    Lin CC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Jiang JK; Yang MH; Chang SC
    J Surg Oncol; 2014 Sep; 110(4):451-7. PubMed ID: 24964758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability.
    Sinicrope FA; Rego RL; Garrity-Park MM; Foster NR; Sargent DJ; Goldberg RM; Wiesenfeld M; Witzig TE; Thibodeau SN; Burgart LJ
    Int J Cancer; 2007 Mar; 120(6):1232-8. PubMed ID: 17187355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer.
    Narayanan S; Kawaguchi T; Peng X; Qi Q; Liu S; Yan L; Takabe K
    Sci Rep; 2019 Sep; 9(1):13455. PubMed ID: 31530839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
    Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM
    Br J Cancer; 2015 Sep; 113(6):979-88. PubMed ID: 26305864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    Chouhan H; Sammour T; Thomas ML; Moore JW
    J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
    Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
    J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal instability in microsatellite-unstable and stable colon cancer.
    Trautmann K; Terdiman JP; French AJ; Roydasgupta R; Sein N; Kakar S; Fridlyand J; Snijders AM; Albertson DG; Thibodeau SN; Waldman FM
    Clin Cancer Res; 2006 Nov; 12(21):6379-85. PubMed ID: 17085649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
    Peng L; Li Y; Gu H; Xiang L; Xiong Y; Wang R; Zhou H; Wang J
    Aging (Albany NY); 2021 Mar; 13(6):9043-9055. PubMed ID: 33714943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis.
    De Smedt L; Lemahieu J; Palmans S; Govaere O; Tousseyn T; Van Cutsem E; Prenen H; Tejpar S; Spaepen M; Matthijs G; Decaestecker C; Moles Lopez X; Demetter P; Salmon I; Sagaert X
    Br J Cancer; 2015 Jul; 113(3):500-9. PubMed ID: 26068398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.